Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: INTEGRAL MOLECULAR INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-06-30 to 2024-06-29
Current total value of award: $600000
Description: ADJUVANT TARGET DISCOVERY FOR VACCINES AND FOR AUTOIMMUNE AND ALLERGIC DISEASES.